Brownstone » Articles for Sasha Latypova

Sasha Latypova

Sasha Latypova is a former pharmaceutical R&D executive. She worked in the industry for 25 years, and ultimately owned and managed several contract research organizations working on clinical trials for 60+pharma companies, including Pfizer, AstraZeneca, J&J, GSK, Novartis and many others. She worked many years in cardiovascular safety assessments and interacted with the FDA and other regulatory agencies on these matters on behalf of her clients and as part of the FDA Cardiovascular Safety Research Consortium.

CONTACT / FOLLOW:

Proof that the Vaccines Were a Military-Backed Countermeasure

Sasha Latypova May 3, 2023 Policy 7 minute read

SHARE | PRINT | EMAIL

“Whole of nation” is closely associated with “whole of government” terminology. Both presented as feel-good ideas in plain text, but in fact these words signal a usurpation of power by the militarized executive branch of the government. Public private partnerships – so beloved by sellouts in academia, pharma, medicine and defense – are another closely associated term.

The Waiting-For-Pandemic Cult of Biodefense

Sasha Latypova March 31, 2023 History, Policy 11 minute read

SHARE | PRINT | EMAIL

The Government mafia (HHS, NIH, DOD, DARPA, BARDA, DTRA, etc, etc,) and their vassals in academia, the biopharma industry, and media have all been feeding at the “biodefense” money trough for decades. What can be better than an invisible threat to justify printing and spending truckloads of money for mega-defense/research contracts, while flying to the global champagne-caviar events and giving each other diverse-inclusive-sustainable science awards?